Attached files
| file | filename |
|---|---|
| 10-K/A - AMENDMENT NO.2 TO ANNUAL REPORT - ABVC BIOPHARMA, INC. | f10k2016a2_americanbrivision.htm |
| EX-32.2 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2016a2ex32ii_americanbri.htm |
| EX-31.2 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2016a2ex31ii_americanbri.htm |
| EX-31.1 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2016a2ex31i_americanbri.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF SARBANES-OXLEY ACT OF 2002
I, Eugene Jiang, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
| 1. | The Annual Report on Form 10-K/A Amendment No. 2 of American BriVision (Holding) Corporation (the “Company”) for the period ended September 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (U.S.C. 78m or 78o(d)); and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 22, 2017 | By: | /s/ Eugene Jiang |
| Eugene Jiang | ||
|
Chief Executive Officer (Principal Executive Officer) |
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of a separate disclosure document.